Long-term medical treatment of ectopic ACTH syndrome

Southern Medical Journal

Volumn 91, Issue 11, 1998, Pages 1014-1018

  Comi, Richard J ^a   Gorden, Phillip ^b  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; DEXAMETHASONE; DOXORUBICIN; FLUOROURACIL; HYDROCORTISONE; KETOCONAZOLE; METHOTREXATE; METYRAPONE; MITOTANE; OCTREOTIDE;

ADOLESCENT; ADULT; ARTICLE; BRONCHUS CARCINOID; CASE REPORT; CLINICAL FEATURE; CUSHING SYNDROME; DRUG EFFECT; ECTOPIC CORTICOTROPIN PRODUCTION; ENDOCRINE TUMOR; FEMALE; HUMAN; HYPERCORTISOLISM; LONG TERM CARE; MALE; PANCREAS ISLET CELL CARCINOMA; STEROIDOGENESIS; THYMOMA;

EID: 0031727122     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199811000-00004     Document Type: Article

References (25)

1. Gorden P, Becker C, Levey G, et al: Efficacy of aminoglutethimide in the ectopic ACTH syndrome. J Clin Endocrinol Metab 1968; 28:921-923
2. Cheung N, Boyages S: Failure of somatostatin analogue to control Cushing's syndrome in two cases of ACTH-producing carcinoid tumors. Clin Endocrinol 1992; 36:361-367
3. Bertegna X, Favrad Courie C, Escourelli H, et al: Suppression of ectopic adrenocorticotropin secreting by long acting somatostatin analogue octreotide. J Clin Endocrinol Metab 1989; 68:988-991
4. Carey R, Orth D, Hartman W: Malignant melanoma with ectopic production of adrenocorticotropic hormone: palliative treatment with inhibitors of adrenal steroid biosynthesis. J Clin Endocrinol Metab 1973; 36:482-487
5. Coll R, Horner I, Krareim Z, et al: Successful metyrapone therapy of the ectopic ACTH syndrome. Arch Intern Med 1968; 121:549-553
6. Duquenne M, Dousset B, Weryha G, et al: Paradoxical effect of octreotide in neoplastic inappropriate corticotropin secretion. Lancet 1991; 338:1407-1408
7. Engelhardt D, Jacob K, Doerr H: Different therapeutic efficacy of ketoconazole in patients with Cushing's syndrome. Klin Wochenschr 1989; 67:241-247
8. Farwell A, Devlin J, Stewart J: Total suppression of cortisol excretion by ketoconazole in the therapy of the ectopic adrenocorticotropic hormone syndrome. Am J Med 1988; 84:1063-1066
9. Hoffman D, Brigham B: The use of ketoconazole in ectopic adrenocorticotropic hormone syndrome. Cancer 1991; 67:1447-1449
10. Lamberts S, Tilanus H, Klooswijk A, et al: Successful treatment with SMS 201-995 of Cushing's syndrome caused by ectopic adrenocorticotropin secretion from a metastatic gastrin secreting islet cell carcinoma. J Clin Endocrinol Metab 1988; 67:1080-1083
11. Malchoff C, Orth D, Abboud C, et al: Ectopic ACTH syndrome caused by a bronchial carcinoid tumor responsive to dexamethasone, metyrapone and corticotropin releasing factor. Am J Med 1988; 84:760-764
12. Maton P: The use of the long acting somatostatin analogue, octreotide acetate, in patients with islet cell tumors. Gastrointest Clin North Am 1989; 18:897-922
13. Rusniewski P, Girad F, Benamouzig R, et al: Long acting somatostatin treatment of paraneoplastic Cushing's disease in a case of Zollinger-Ellison syndrome. Gut 1988; 29:838-842
14. Shepherd F, Hoffert B, Evans W, et al: Ketoconazole. use in the treatment of ectopic adrenocorticotropic hormone production and Cushing's syndrome in small cell lung cancer. Arch Intern Med 1985; 145:863-864
15. Shepherd F, Lasky J, Evans W, et al: Cushing's syndrome associated with ectopic corticotropin production and small cell lung cancer. J Clin Oncol 1992; 10:1021-1027
16. Sonino N, Boscaro M, Paletta A, et al: Ketoconazole treatment in Cushing's syndrome: experience in 34 patients. Clin Endocrinol 1991; 35:347-352
17. Sparagna M, Ackerman L: Positive iodine 131 6 beta iodomethyl 19 norcholesterol (NP 59) adrenal images can precede return of adrenocortical function after o,p'-DDD treatment. Clin Nucl Med 1988; 13:348-351
18. Steen R, Kapelrud H, Haug E, et al: In vivo and in vitro inhibition by ketoconazole of ACTH secretion from a human thymic carcinoid tumor. Acta Endocrinol 1991; 125:331-334
19. Suzuki S, Hashizuma K, Kobayashi M, et al: Somatostatin analogue (SMS 201-995) decreases plasma levels of corticotropin (ACTH) and corticotropin releasing hormone in a patient with ectopic ACTH syndrome. Endocrinol Japan 1990; 37:923-932
20. Taborin A, Navarrone A, Guerin J, et al: Use of ketoconazole in the treatment of Cushing's disease and ectopic ACTH syndrome. Clin Endocrinol 1991; 34:63-69
21. Thoren M, Adamsen V, Sjoberg H: Aminoglutethimide and metyrapone in the management of Cushing's syndrome. Acta Endocrinol 1985; 109:451-457
22. Verhelst J, Trainer P, Hewlett A, et al: Short and long term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. Clin Endocrinol 1991; 35:169-178
23. Kornely E, Schlaghecke R, Horster F: Palliative therapy of an ectopic Cushing's syndrome due to a metastatic carcinoid tumor, Klin Wochenschr 1991; 69:173-176
24. Vignati F, Loli P: Additive effect of ketoconazole and octreotide in the treatment of severe adrenocorticotropin dependent hyercortisolism. J Clin Endocrinol Metab 1996; 81:2885-2890
25. Liddle, GW: Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 1960; 20:1539-1561